The rollout of new Covid-19 pills has exposed a potentially costly hole in how the government and healthcare companies are managing the pandemic drug response.

Pharmacies that dispense the pills are pushing back and some are threatening to halt supplies if they don’t get more funds to cover the gap.

This post first appeared on wsj.com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Several hundred doses of Moderna vaccine may have spoiled at Vermont hospital

Several hundred doses of Moderna’s Covid-19 vaccine may have spoiled at a…

10 Chinese aircraft crossed Taiwan Strait median line, Taiwan says

Ten Chinese aircraft crossed the median line of the Taiwan Strait, normally an unofficial…

Biden faces legacy-defining challenge in salvaging his Build Back Better bill

WASHINGTON — President Joe Biden has spent nearly half a century in…

China had nearly 2 million excess deaths after sudden end of ‘zero-Covid,’ U.S. study finds

HONG KONG — There were almost 2 million excess deaths in the…